PerkinElmer collaborates with FIGO to help combat pre-eclampsia

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its collaboration with the International Federation of Gynecology and Obstetrics (FIGO), a not-for-profit, professional association with 130 member organizations that convenes obstetrical and gynecological associations from across the globe. FIGO is dedicated to improving women’s health and reducing disparities in available healthcare to women and newborn babies, along with advancing the science and practice of obstetrics and gynecology.

PerkinElmer will sponsor FIGO’s Non-Communicable Disease (NCD) Committee through an annual unrestricted educational grant. The Committee will focus on prediction (ideally in the 1st Trimester) and prevention of pregnancy complications such as pre-eclampsia, pre-term labor, hyperglycemia in pregnancy, and fetal growth restriction as a consequence of common NCDs. The Committee will work together with physicians and health organizations to help develop guidelines and practice recommendations.

Professor Moshe Hod from FIGO's Pregnancy & NCDs Committee highlights

“FIGO recently formed this Committee on maternal and offspring health and prevention of NCDs to emphasize the importance of health and nutrition to improve pregnancy outcomes – such as lowering the incidence of preeclampsia – on a global scale,” “PerkinElmer is at the forefront of diagnostics innovations, and its sponsorship of the NCD Committee will help build the foundation for better overall population health.”

CN Purandare, President FIGO agrees

“Non-communicable diseases are a growing global problem and the link with women’s health is clear; thus, it’s essential for FIGO’s NCD Committee to be pushing this agenda. FIGO is delighted to be partnering with PerkinElmer on this important issue,”